No Appeal of LDT/FDA Lawsuit

No Appeal of LDT/FDA Lawsuit

The FDA had until May 30 to appeal U.S. District Court Judge Sean D. Jordan's decision to vacate the agency's Final Rule seeking to regulate laboratory developed tests (LDTs). The federal government declined to appeal the judge's decision meaning the Texas District Court's decision to vacate, in its entirety, the FDA's attempt to regulate LDTs as medical devices stands.

Read ACLA’s full lawsuit.

Read the Final Judgment.

 

Prior Authorization Legislation Takes Center Stage at Joint Hearing on Health Care Affordability

Prior Authorization Legislation Takes Center Stage at Joint Hearing on Health Care Affordability

A joint hearing held on Jan. 22 by the U.S. House of Representatives Energy & Commerce Subcommittee on Health and the Ways and Means Committee hosted...

Read More
Payer Update for Blue Cross Blue Shield New Jersey

Payer Update for Blue Cross Blue Shield New Jersey

TELCOR has identified ongoing processing challenges with BCBS New Jersey that laboratories should be aware of. When claims require medical records,...

Read More
Payer Update for BCBS Nebraska

Payer Update for BCBS Nebraska

TELCOR has identified a recent process change with BCBSNebraska impacting payment timelines. As of November 1, 2025, BCBSNE adjustedits payment...

Read More